Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SHA:688796)

SHA:688796 Statistics

Total Valuation

SHA:688796 has a market cap or net worth of CNY 28.54 billion. The enterprise value is 28.67 billion.

Market Cap	28.54B
Enterprise Value	28.67B

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	336.12M
Shares Outstanding	n/a
Shares Change (YoY)	-0.31%
Shares Change (QoQ)	-0.38%
Owned by Insiders (%)	14.07%
Owned by Institutions (%)	19.04%
Float	154.95M

Valuation Ratios

The trailing PE ratio is 215.89 and the forward PE ratio is 182.97.

PE Ratio	215.89
Forward PE	182.97
PS Ratio	23.97
PB Ratio	31.84
P/TBV Ratio	32.62
P/FCF Ratio	84.28
P/OCF Ratio	74.12
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 78.15, with an EV/FCF ratio of 84.66.

EV / Earnings	216.86
EV / Sales	24.74
EV / EBITDA	78.15
EV / EBIT	139.36
EV / FCF	84.66

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.69.

Current Ratio	1.89
Quick Ratio	1.51
Debt / Equity	0.69
Debt / EBITDA	1.50
Debt / FCF	1.81
Interest Coverage	3.26

Financial Efficiency

Return on equity (ROE) is 16.11% and return on invested capital (ROIC) is 21.05%.

Return on Equity (ROE)	16.11%
Return on Assets (ROA)	6.20%
Return on Invested Capital (ROIC)	21.05%
Return on Capital Employed (ROCE)	12.10%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	911,882
Profits Per Employee	101,236
Employee Count	1,306
Asset Turnover	0.48
Inventory Turnover	33.60

Taxes

In the past 12 months, SHA:688796 has paid 17.43 million in taxes.

Income Tax	17.43M
Effective Tax Rate	11.65%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	55.48
Average Volume (20 Days)	3,352,770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688796 had revenue of CNY 1.19 billion and earned 132.21 million in profits. Earnings per share was 0.33.

Revenue	1.19B
Gross Profit	946.48M
Operating Income	243.95M
Pretax Income	149.64M
Net Income	132.21M
EBITDA	382.48M
EBIT	243.95M
Earnings Per Share (EPS)	0.33

Balance Sheet

The company has 486.84 million in cash and 614.18 million in debt, with a net cash position of -127.34 million.

Cash & Cash Equivalents	486.84M
Total Debt	614.18M
Net Cash	-127.34M
Net Cash Per Share	n/a
Equity (Book Value)	896.58M
Book Value Per Share	2.23
Working Capital	418.61M

Cash Flow

In the last 12 months, operating cash flow was 385.07 million and capital expenditures -46.42 million, giving a free cash flow of 338.66 million.

Operating Cash Flow	385.07M
Capital Expenditures	-46.42M
Free Cash Flow	338.66M
FCF Per Share	n/a

Margins

Gross margin is 79.48%, with operating and profit margins of 20.48% and 11.10%.

Gross Margin	79.48%
Operating Margin	20.48%
Pretax Margin	12.56%
Profit Margin	11.10%
EBITDA Margin	32.12%
EBIT Margin	20.48%
FCF Margin	28.44%

Dividends & Yields

SHA:688796 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.31%
Shareholder Yield	0.31%
Earnings Yield	0.46%
FCF Yield	1.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688796 has an Altman Z-Score of 1.4 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.4
Piotroski F-Score	7